Partner Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$546K Buy
+1,839
New +$510K 3.92% 7
2017
Q3
Sell
-248
Closed -$67K 86
2017
Q2
$67K Sell
248
-8,115
-97% -$2.15M 0.09% 85
2017
Q1
$2.29M Sell
8,363
-4,570
-35% -$1.29M 2.78% 5
2016
Q4
$3.67M Buy
12,933
+1,105
+9% +$328K 4.86% 2
2016
Q3
$3.7M Buy
11,828
+4,689
+66% +$1.39M 5.49% 1
2016
Q2
$1.73M Buy
+7,139
New +$1.88M 2.82% 6
2013
Q3
Sell
-3,292
Closed -$708K 76
2013
Q2
$708K Buy
+3,292
New +$703K 0.16% 51

Other funds holding BIIB

Partner Investment Management's BIIB Position: Q4 2019 in Review

Partner Investment Management opened a new position in Biogen (BIIB) in Q4 2019: 1,839 shares worth $546K. The stake represents 3.92% of the portfolio and ranks #7 among its holdings. This is a return to the name: Partner Investment Management previously reported a position in BIIB as recently as Q2 2017.

Partner Investment Management first reported a position in BIIB in Q2 2013 and has held it in 7 quarters since. The position peaked at $3.7M in Q3 2016. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Partner Investment Management held 1,839 shares of Biogen worth $546K as of Q4 2019.
  • Biogen was a new Partner Investment Management position in Q4 2019.
  • Biogen made up 3.92% of Partner Investment Management's portfolio in Q4 2019, its #7 holding.
  • Partner Investment Management first reported a position in Biogen in Q2 2013 and has held it in 7 quarters since.
  • Partner Investment Management's Biogen position peaked at $3.7M in Q3 2016.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.